Related Experiment Video

Updated: Aug 7, 2026

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
07:48

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

Functional screen for genes responsible for tamoxifen resistance in human breast cancer cells

Danielle Meijer1, Ton van Agthoven, Peter T Bosma

  • 1Department of Pathology, Josephine Nefkens Institute, Erasmus MC-University Medical Center, Rotterdam, the Netherlands.

Molecular Cancer Research : MCR
|June 17, 2006
PubMed

Insights

Researchers identified genes driving tamoxifen resistance in breast cancer using a novel screening method. They discovered that activating the mitogen-activated protein kinase pathway and the BCAR4 gene contribute to endocrine therapy resistance.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Antiestrogens like tamoxifen are crucial for estrogen receptor-positive breast cancer treatment.
  • Tamoxifen resistance is a significant challenge in advanced breast cancer, with underlying mechanisms requiring further elucidation.
  • Understanding tamoxifen resistance mechanisms is vital for developing effective therapeutic strategies.

Purpose of the Study:

  • To identify novel genes involved in the development of tamoxifen resistance in breast cancer.
  • To develop and utilize a rapid screening method for discovering resistance-associated genes.
  • To investigate the role of identified genes in conferring resistance to antiestrogen therapy.

Main Methods:

  • Utilized retroviral cDNA libraries from human and mouse sources to infect tamoxifen-sensitive human breast cancer cells (ZR-75-1).
  • Selected infected cells for proliferation in the presence of 4-hydroxy-tamoxifen (OH-TAM) to isolate resistant phenotypes.
  • Identified integrated cDNAs via sequence similarity searches and validated candidate genes through ectopic expression studies.

Main Results:

  • Isolated 25 candidate genes from 155 resistant cell colonies, with seven genes consistently identified.
  • Identified key regulators of the mitogen-activated protein kinase (MAPK) pathway, including EGFR, PDGFRA, PDGFRB, CSF1R, NRG1, and FGF17, as contributors to resistance.
  • Discovered and validated a novel gene, BCAR4 (breast cancer antiestrogen resistance 4), which confers OH-TAM resistance and promotes anchorage-independent growth.

Conclusions:

  • Retroviral cDNA library screening is an effective method for identifying genes associated with tamoxifen resistance in breast cancer.
  • The MAPK pathway and BCAR4 are critical players in the development of endocrine resistance.
  • Targeting the MAPK pathway and BCAR4 may offer new therapeutic avenues for tamoxifen-resistant breast cancer.

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...